{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:03:14Z","timestamp":1787169794803,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Oral submucous fibrosis<\/jats:italic>\n                      (OSMF) is a precancerous condition associated with the use of betel\/areca nut in various forms. It is characterized by restricted mouth opening, tongue protrusion and cheek rigidity. Oral submucous fibrosis, is primarily prevalent among the people of the Indian subcontinent and it has been reported that about one third of the OSMF patients develop squamous cell carcinoma.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Endoglin (CD-105)<\/jats:italic>\n                      is a hypoxia induced protein and a potential marker for activated endothelial cells which signify tumorigenic neoangiogenesis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To determine expression of CD105 and study relation of neoangiogenesis with the clinical staging and histopathological grading of oral submucous fibrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Method:<\/jats:title>\n                    <jats:p>Immunohistochemical expression of CD105 was evaluated on forty nine (49) paraffin-embedded tissue sections of diagnosed cases of OSF and seven (7) control samples of healthy volunteers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>There were 13 cases in Stage A, 11 cases in Stage B, 13 cases in Stage C, and 12 cases in Stage D. There were 4 cases in Grade 1 (Very early), 19 cases in Grade 2 (Early), 19 cases in Grade 3 (Moderately advance) and 7 cases in Grade 4 (Advance).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The present study was first immunohistochemical study to demonstrate MVD, MVP and MVAP with CD105 expression in OSMF cases. However, well-designed studies with larger sample size is required to validate CD105 as a reliable biomarker for malignant transformation in future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jomfp.jomfp_67_24","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T08:01:44Z","timestamp":1735632104000},"page":"589-595","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["ENDOGLIN (CD105): A marker of tumour vasculature for assessment of malignant potential of oral submucous fibrosis"],"prefix":"10.4103","volume":"28","author":[{"given":"Subraj","family":"Shetty","sequence":"first","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Microbiology, D. Y. PATIL University, School of Dentistry, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Treville","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Microbiology, D. Y. PATIL University, School of Dentistry, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Tamgadge","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Microbiology, D. Y. PATIL University, School of Dentistry, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kale","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Microbiology, D. Y. PATIL University, School of Dentistry, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Kamat","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Microbiology, D. Y. PATIL University, School of Dentistry, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourab","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Pathology and Microbiology, D. Y. PATIL University, School of Dentistry, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"R1-20250108","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/0970-9290.33785","article-title":"Oral submucous fibrosis: A clinico-histopathological study in Chennai","volume":"18","author":"Kumar","year":"2007","journal-title":"Indian J Dent Res"},{"key":"R2-20250108","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2010.04.004","article-title":"Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis","volume":"46","author":"Desai","year":"2010","journal-title":"Oral Oncol"},{"key":"R3-20250108","first-page":"985","article-title":"Oral submucous fibrosis: Etiology, pathogenesis, and future research","volume":"72","author":"Rajendran","year":"1994","journal-title":"Bull World Health Organ"},{"key":"R4-20250108","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0528.1985.tb00468.x","article-title":"Malignant transformation rate in oral submucous fibrosis over a 17-year period","volume":"13","author":"Murti","year":"1985","journal-title":"Community Dent Oral Epidemiol"},{"key":"R5-20250108","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4103\/0973-1482.181186","article-title":"Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study","volume":"14","author":"Pammar","year":"2018","journal-title":"J Cancer Res Ther"},{"key":"R6-20250108","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0065-230X(08)60946-X","article-title":"Tumor angiogenesis","volume":"43","author":"Folkman","year":"1985","journal-title":"Adv Cancer Res"},{"key":"R7-20250108","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1096\/fasebj.6.3.1371260","article-title":"Angiogenesis in the female reproductive system","volume":"6","author":"Reynolds","year":"1992","journal-title":"FASEB J"},{"key":"R8-20250108","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00665960","article-title":"Vascular permeability factor (VPF, VEGF) in tumor biology","volume":"12","author":"Senger","year":"1993","journal-title":"Cancer Metastasis Rev"},{"key":"R9-20250108","first-page":"253","article-title":"New marker of angiogenesis CD105 (endoglin): Diagnostic, prognostic and therapeutic role","volume":"39","author":"Legan","year":"2005","journal-title":"Radiol Oncol"},{"key":"R10-20250108","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0714.2005.00325.x","article-title":"Molecular pathogenesis of oral submucous fibrosis\u2013A collagen metabolic disorder","volume":"34","author":"Rajalalitha","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"R11-20250108","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-90-481-3186-0_3","article-title":"Tumor angiogenesis in cancers. Expression of CD105 marker","volume":"7","author":"Tokunaga","year":"2010","journal-title":"Method Cancer Diagn Ther Prognosis"},{"key":"R12-20250108","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1078-0432.CCR-07-4478","article-title":"Endoglin (CD105): A marker of tumor vasculature and potential target for therapy","volume":"14","author":"Dallas","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R13-20250108","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0714.2010.00888.x","article-title":"CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma","volume":"39","author":"Marioni","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"R14-20250108","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0714.1995.tb01209.x","article-title":"Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases","volume":"24","author":"Lai","year":"1995","journal-title":"J Oral Pathol Med"},{"key":"R15-20250108","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/0030-4220(66)90367-7","article-title":"Oral submucous fibrosis","volume":"22","author":"Pindborg","year":"1966","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"R16-20250108","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/(SICI)1096-9896(199808)185:4<394::AID-PATH117>3.0.CO;2-S","article-title":"Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis","volume":"185","author":"Lee","year":"1998","journal-title":"J Pathol"},{"key":"R17-20250108","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.oraloncology.2005.08.005","article-title":"Oral submucous fibrosis: Review on aetiology and pathogenesis","volume":"42","author":"Tilakaratne","year":"2006","journal-title":"Oral Oncol"},{"key":"R18-20250108","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/154405910808701111","article-title":"Areca-treated fibroblasts enhance tumorigenesis of oral epithelial cells","volume":"87","author":"Lu","year":"2008","journal-title":"J Dent Res"},{"key":"R19-20250108","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V90.9.3322","article-title":"Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphate dylinositol3-kinase\/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element","volume":"90","author":"Mazure","year":"1997","journal-title":"Blood"},{"key":"R20-20250108","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/2211552811201040347","article-title":"Immunohistochemical expression of vascular endothelial growth factor (VEGF) and its possible role in tumor progression during malignant transformation of atrophic epithelium in oral submucous fibrosis","volume":"1","author":"Desai","year":"2012","journal-title":"Curr Angiogenesis"},{"key":"R21-20250108","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2334\/josnusd.56.173","article-title":"Morphometric analysis of the mucosal vasculature in oral submucous fibrosis and its comparison with oral squamous cell carcinoma","volume":"56","author":"Murgod","year":"2014","journal-title":"J Oral Sci"},{"key":"R22-20250108","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1096\/fj.02-0634rev","article-title":"CD105 is important for angiogenesis: Evidence and potential applications","volume":"17","author":"Duff","year":"2003","journal-title":"FASEB J"},{"key":"R23-20250108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1054\/bjom.1999.0062","article-title":"Clinical and functional staging of oral submucous fibrosis","volume":"38","author":"Haider","year":"2000","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R24-20250108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03008011","article-title":"Clinical profile and serum beta-carotene levels in oral submucous fibrosis","volume":"57","author":"Raina","year":"2005","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"R25-20250108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0714.2006.00485.x","article-title":"Oral submucous fibrosis: Study of 1000 cases from central India","volume":"36","author":"Hazarey","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"R26-20250108","first-page":"83","article-title":"Characterisation and quantification of mucosal vasculature in oral submucous fibrosis","volume":"16","author":"Rajendran","year":"2005","journal-title":"Indian J Dent Res"},{"key":"R27-20250108","first-page":"257","article-title":"Morphometric analysis in potentially malignant head and neck lesions: Oral submucous fibrosis","volume":"11","author":"Singh","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"R28-20250108","first-page":"55","article-title":"A morphometric study on the microvessel in oral submucous fibrosis","volume":"25","author":"Fang","year":"2000","journal-title":"Hunan Yi Ke Da Xue XueBao"},{"key":"R29-20250108","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0970-9290.80009","article-title":"Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis","volume":"22","author":"Sabarinath","year":"2011","journal-title":"Indian J Dent Res"},{"key":"R30-20250108","doi-asserted-by":"crossref","first-page":"e12443","DOI":"10.1111\/jicd.12443","article-title":"Ki 67, CD105 and \u03b1- smooth muscle actin expression in disease progression model of oral submucous fibrosis","volume":"00","author":"Gadbail","year":"2019","journal-title":"J Invent Clin Dent"},{"key":"R31-20250108","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3109\/00016356409058581","article-title":"Clinical aspects of oral submucous fibrosis","volume":"22","author":"Pindborg","year":"1964","journal-title":"Acta Odontol Scand"}],"container-title":["Journal of Oral and Maxillofacial Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_67_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:02Z","timestamp":1787166782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jomfp.jomfp_67_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jomfp.jomfp_67_24","relation":{},"ISSN":["0973-029X","1998-393X"],"issn-type":[{"value":"0973-029X","type":"print"},{"value":"1998-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}